First Time Loading...

DaVita Inc
NYSE:DVA

Watchlist Manager
DaVita Inc Logo
DaVita Inc
NYSE:DVA
Watchlist
Price: 132.77 USD 0.02% Market Closed
Updated: Apr 26, 2024

Intrinsic Value

DaVita, Inc. engages in the provision of medical care services. [ Read More ]

The intrinsic value of one DVA stock under the Base Case scenario is 192.62 USD. Compared to the current market price of 132.77 USD, DaVita Inc is Undervalued by 31%.

Key Points:
DVA Intrinsic Value
Base Case
192.62 USD
Undervaluation 31%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
DaVita Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling DVA stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
DaVita Inc

Provide an overview of the primary business activities
of DaVita Inc.

What unique competitive advantages
does DaVita Inc hold over its rivals?

What risks and challenges
does DaVita Inc face in the near future?

Has there been any significant insider trading activity
in DaVita Inc recently?

Summarize the latest earnings call
of DaVita Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for DaVita Inc.

Provide P/S
for DaVita Inc.

Provide P/E
for DaVita Inc.

Provide P/OCF
for DaVita Inc.

Provide P/FCFE
for DaVita Inc.

Provide P/B
for DaVita Inc.

Provide EV/S
for DaVita Inc.

Provide EV/GP
for DaVita Inc.

Provide EV/EBITDA
for DaVita Inc.

Provide EV/EBIT
for DaVita Inc.

Provide EV/OCF
for DaVita Inc.

Provide EV/FCFF
for DaVita Inc.

Provide EV/IC
for DaVita Inc.

Show me price targets
for DaVita Inc made by professional analysts.

What are the Revenue projections
for DaVita Inc?

How accurate were the past Revenue estimates
for DaVita Inc?

What are the Net Income projections
for DaVita Inc?

How accurate were the past Net Income estimates
for DaVita Inc?

What are the EPS projections
for DaVita Inc?

How accurate were the past EPS estimates
for DaVita Inc?

What are the EBIT projections
for DaVita Inc?

How accurate were the past EBIT estimates
for DaVita Inc?

Compare the revenue forecasts
for DaVita Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of DaVita Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of DaVita Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of DaVita Inc compared to its peers.

Compare the P/E ratios
of DaVita Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing DaVita Inc with its peers.

Analyze the financial leverage
of DaVita Inc compared to its main competitors.

Show all profitability ratios
for DaVita Inc.

Provide ROE
for DaVita Inc.

Provide ROA
for DaVita Inc.

Provide ROIC
for DaVita Inc.

Provide ROCE
for DaVita Inc.

Provide Gross Margin
for DaVita Inc.

Provide Operating Margin
for DaVita Inc.

Provide Net Margin
for DaVita Inc.

Provide FCF Margin
for DaVita Inc.

Show all solvency ratios
for DaVita Inc.

Provide D/E Ratio
for DaVita Inc.

Provide D/A Ratio
for DaVita Inc.

Provide Interest Coverage Ratio
for DaVita Inc.

Provide Altman Z-Score Ratio
for DaVita Inc.

Provide Quick Ratio
for DaVita Inc.

Provide Current Ratio
for DaVita Inc.

Provide Cash Ratio
for DaVita Inc.

What is the historical Revenue growth
over the last 5 years for DaVita Inc?

What is the historical Net Income growth
over the last 5 years for DaVita Inc?

What is the current Free Cash Flow
of DaVita Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for DaVita Inc.

Financials

Balance Sheet Decomposition
DaVita Inc

Current Assets 3.1B
Cash & Short-Term Investments 391.7m
Receivables 2.4B
Other Current Assets 330.3m
Non-Current Assets 13.8B
Long-Term Investments 593.7m
PP&E 5.6B
Intangibles 7.3B
Other Non-Current Assets 271.3m
Current Liabilities 2.6B
Accounts Payable 514.5m
Accrued Liabilities 1.1B
Other Current Liabilities 980.7m
Non-Current Liabilities 13.2B
Long-Term Debt 8.3B
Other Non-Current Liabilities 4.9B
Efficiency

Earnings Waterfall
DaVita Inc

Revenue
12.1B USD
Cost of Revenue
-8.3B USD
Gross Profit
3.8B USD
Operating Expenses
-2.2B USD
Operating Income
1.6B USD
Other Expenses
-909.5m USD
Net Income
691.5m USD

Free Cash Flow Analysis
DaVita Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

DVA Profitability Score
Profitability Due Diligence

DaVita Inc's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional ROE
ROE is Increasing
Positive Gross Profit
64/100
Profitability
Score

DaVita Inc's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

DVA Solvency Score
Solvency Due Diligence

DaVita Inc's solvency score is 25/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
Positive Net Debt
25/100
Solvency
Score

DaVita Inc's solvency score is 25/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DVA Price Targets Summary
DaVita Inc

Wall Street analysts forecast DVA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DVA is 134.64 USD with a low forecast of 115.14 USD and a high forecast of 152.25 USD.

Lowest
Price Target
115.14 USD
13% Downside
Average
Price Target
134.64 USD
1% Upside
Highest
Price Target
152.25 USD
15% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

DVA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

DVA Price
DaVita Inc

1M 1M
-2%
6M 6M
+71%
1Y 1Y
+54%
3Y 3Y
+17%
5Y 5Y
+139%
10Y 10Y
+92%
Annual Price Range
132.77
52w Low
73.2
52w High
139.21
Price Metrics
Average Annual Return 13.52%
Standard Deviation of Annual Returns 39.83%
Max Drawdown -25%
Shares Statistics
Market Capitalization 11.8B USD
Shares Outstanding 87 700 000
Percentage of Shares Shorted 8.19%

DVA Return Decomposition
Main factors of price return

What is price return decomposition?

DVA News

Other Videos

Company Profile

DaVita Inc Logo
DaVita Inc

Country

United States of America

Industry

Health Care

Market Cap

11.8B USD

Dividend Yield

0%

Description

DaVita, Inc. engages in the provision of medical care services. The company is headquartered in Denver, Colorado and currently employs 69,000 full-time employees. The firm's principal business is to provide dialysis and related lab services to patients. The company is engaged in providing care delivery, referred to as United States (U.S.) dialysis business. The firm also operate various ancillary services, including its international operations, as well as its corporate administrative support. Its U.S. dialysis business is a provider of kidney dialysis services for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD) or end stage kidney disease (ESKD). The firm's ancillary services consist primarily of integrated care and disease management, clinical research programs and physician services, as well as its international operations. The firm's international dialysis operations provides dialysis and administrative services through a total of 333 outpatient dialysis centers located in ten countries outside of the United States.

Contact

COLORADO
Denver
2000 16th St
+13105362668.0
https://www.davita.com/

IPO

1995-10-31

Employees

69 000

Officers

CEO & Executive Director
Mr. Javier J. Rodriguez
CFO & Treasurer
Mr. Joel Ackerman
Chief Legal & Public Affairs Officer
Ms. Kathleen Alyce Waters
Chief Compliance Officer
Mr. James O. Hearty
Chief Operating Officer of Kidney Care
Mr. Michael David Staffieri
Group VP & Chief Accounting Officer
Mr. Christopher Michael Berry
Show More
Vice President of Investor Relations
Mr. Jim Gustafson
Chief People Officer
Mr. Kenneth Gardner Smith
Chief Transformation Officer of U.S. Kidney Care Business
Mr. Misha Palecek
Chief Medical Officer of Kidney Care
Dr. Jeffrey Allen Giullian
Show Less

See Also

Discover More
What is the Intrinsic Value of one DVA stock?

The intrinsic value of one DVA stock under the Base Case scenario is 192.62 USD.

Is DVA stock undervalued or overvalued?

Compared to the current market price of 132.77 USD, DaVita Inc is Undervalued by 31%.